Toshiba Announced FDA approval of Auto-IMT Ultrasound Software


Feb 16th 2011 :- For physicians, the ability to streamline exams for determining a patient’s risk for cardiovascular disease is important in determining the patient’s clinical pathway. To enhance diagnostic efficiency, Toshiba America Medical Systems, Inc. has introduced Auto-IMTTM, an ultrasound software tool that can measure the thickness of the intima-media layers of the carotid artery, for evaluating an asymptomatic patient’s risk of developing cardiovascular disease. Toshiba has recently received FDA clearance for Auto-IMT, and it is now available on the AplioTM XG, Aplio MX and XarioTM XG ultrasound systems.

David Parlato, director, Clinical Operations, Midwest Ultrasound commented, Auto-IMT has helped us reduce the time it takes to evaluate carotid artery wall thickness from 45 minutes to less than 10 minutes, allowing us to evaluate more patients in less time.

Tomo Hasegawa, director, Ultrasound Business Unit, Toshiba said, Measuring IMT at a faster pace helps identify high-risk patients before a cardiac episode occurs, which we believe leads to better patient outcomes.